Ethanol feeding induces insulin resistance with enhanced PI 3-kinase activation

Author(s): Onishi Y, Honda M, Ogihara T, Sakoda H, Anai M, et al.

Abstract

High ethanol intake is considered to impair insulin sensitivity. In the present study, we investigated the acute and chronic effects of ethanol intake on glucose metabolism and insulin signal transduction. Hyperinsulinemic-euglycemic clamp studies revealed 70% and 51% decreases in the glucose infusion rate, 52% and 31% decreases in the glucose utilization rate, and 6.6- and 8.0-fold increases in hepatic glucose in continuous- and acute-ethanol-loaded rats, respectively. Despite the presence of insulin resistance, alcohol-fed rats showed enhanced tyrosine phosphorylation of insulin receptors, IRS-1 and IRS-2, induced by insulin injection via the portal vein. PI 3-kinase activities associated with IRSs and phosphotyrosine also increased significantly as compared with those of controls. These data suggest ethanol intake to be a factor leading to insulin resistance, regardless of whether it is a single or continuous intake. In addition, the insulin signaling step impaired by ethanol feeding is likely to be downstream from PI 3-kinase.

Similar Articles

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines

Author(s): Miller AM, Horiguchi N, Jeong WI, Radaeva S, Gao B

Alcoholic liver disease-related mortality in the United States: 1980-2003

Author(s): Paula H, Asrani SK, Boetticher NC, Pedersen R, Shah VH, et al.

Molecular mechanisms of alcoholic fatty liver

Author(s): Purohit V, Gao B, Song BJ

Insulin resistance in experimental alcohol-induced liver disease

Author(s): de la Monte SM, Yeon JE, Tong M, Longato L, Chaudhry R, et al.

Acute ethanol exposure inhibits insulin signaling in the liver

Author(s): He J, de la Monte S, Wands JR

Alcohol-induced disruption of endocrine signaling

Author(s): Ronis MJ, Wands JR, Badger TM, de la Monte SM, Lang CH, et al.

Acetaldehyde adducts in alcoholic liver disease

Author(s): Setshedi M, Wands JR, Monte SM

The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids

Author(s): de la Monte SM, Longato L, Tong M, DeNucci S, Wands JR

Pioglitazone: side effect and safety profile

Author(s): Shah P, Mudaliar S

Roles of PPARs in NAFLD: Potential therapeutic targets

Author(s): Tailleux A, Wouters K, Staels B

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

Author(s): Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, et al.

Peroxisome proliferator-activated receptor agonist treatment of alcohol-induced hepatic insulin resistance

Author(s): de la Monte SM, Pang M, Chaudhry R, Duan K, Longato L, et al.

Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met

Author(s): Tomita K, Azuma T, Kitamura N, Nishida J, Tamiya G, et al.

Alcohol abuse, endoplasmic reticulum stress and pancreatitis

Author(s): Pandol SJ, Gorelick FS, Gerloff A, Lugea A

Binge ethanol exposure increases liver injury in obese rats

Author(s): Carmiel-Haggai M, Cederbaum AI, Nieto N

Alcoholic foamy degeneration--a pattern of acute alcoholic injury of the liver

Author(s): Uchida T, Kao H, Quispe-Sjogren M, Peters RL

Induction of megamitochondria in the rat liver by N-propyl alcohol and N-butyl alcohol

Author(s): Wakabayashi T, Horiuchi M, Sakaguchi M, Onda H, Iijima M

Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition

Author(s): Ronis MJ, Butura A, Sampey BP, Shankar K, Prior RL, et al.